Skip to main content

Table 1 LV cardiac remodeling levels in Sham, Model and HA + GA group

From: Investigation into the protective effects of hypaconitine and glycyrrhetinic acid against chronic heart failure of the rats

Group

LVIDd (mm)

LVIDs (mm)

Sham

6.68 ± 0.23

3.63 ± 0.36

Model

8.21 ± 0.19##

5.08 ± 0.78#

HA + GA

7.33 ± 0.16**

3.69 ± 0.67*

  1. HA hypaconitine, GA glycyrrhetinic acid, LVIDd LV end-diastolic dimension, LVIDs LV end-systolic dimension. Data were presented as mean ± SD (n = 5). ##P < 0.01 versus Sham group; ∗P < 0.05 and **P < 0.01 versus Model group
Back to article page

BMC Complementary Medicine and Therapies

ISSN: 2662-7671

Contact us